A detailed history of Inscription Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Inscription Capital, LLC holds 18,786 shares of ABBV stock, worth $3.77 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
18,786
Previous 18,944 0.83%
Holding current value
$3.77 Million
Previous $3.25 Million 14.16%
% of portfolio
0.56%
Previous 0.53%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $25,886 - $31,494
-158 Reduced 0.83%
18,786 $3.71 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $36,530 - $42,659
-236 Reduced 1.23%
18,944 $3.25 Million
Q1 2024

Jul 17, 2024

SELL
$159.82 - $182.1 $10,388 - $11,836
-65 Reduced 0.34%
19,180 $3.49 Million
Q1 2024

Apr 10, 2024

BUY
$159.82 - $182.1 $531,880 - $606,028
3,328 Added 20.91%
19,245 $3.5 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $62,057 - $69,891
451 Added 2.92%
15,917 $2.47 Million
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $56,642 - $65,571
424 Added 2.82%
15,466 $2.31 Million
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $47,571 - $59,199
-359 Reduced 2.33%
15,042 $2.03 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $95,731 - $110,249
662 Added 4.49%
15,401 $2.45 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $11,479 - $13,767
-83 Reduced 0.56%
14,739 $2.38 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1.99 Million - $2.29 Million
-14,846 Reduced 50.04%
14,822 $1.99 Million
Q2 2022

Sep 20, 2022

BUY
$137.62 - $174.96 $1.9 Million - $2.42 Million
13,831 Added 87.33%
29,668 $4.54 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $33,918 - $42,083
-257 Reduced 1.6%
15,837 $2.57 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $184,779 - $233,799
1,720 Added 11.97%
16,094 $2.18 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $2.49 Million - $2.82 Million
-23,372 Reduced 61.92%
14,374 $1.55 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $2.4 Million - $2.67 Million
22,771 Added 152.06%
37,746 $4.25 Million
Q1 2021

May 18, 2021

SELL
$102.3 - $112.62 $77,952 - $85,816
-762 Reduced 4.84%
14,975 $1.62 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $39,037 - $52,704
-485 Reduced 2.99%
15,737 $1.69 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $4,725 - $5,545
55 Added 0.34%
16,222 $1.42 Million
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $30,155 - $40,351
-411 Reduced 2.48%
16,167 $1.59 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $18,898 - $28,652
-293 Reduced 1.74%
16,578 $1.26 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $163,735 - $204,867
2,270 Added 15.55%
16,871 $1.49 Million
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $919,570 - $1.11 Million
14,601 New
14,601 $1.11 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $52,625 - $67,267
-801 Closed
0 $0
Q1 2019

May 16, 2019

SELL
$77.14 - $90.79 $19,747 - $23,242
-256 Reduced 24.22%
801 $65,000
Q4 2018

May 16, 2019

BUY
$77.85 - $96.01 $82,287 - $101,482
1,057 New
1,057 $97,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.